Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Consistency matters far more than dose
Tirzepatide is a dual agonist targeting both GLP-1 and GIP receptors, improving insulin sensitivity and promoting fullness, leading to superior weight losssome patients lose over 20%, with an average of 15%
Mike brings more than just a medical perspective to his clients
This precision approach may reduce medication trial-and-error and support sustainable, effective results aligned with your health goals
Preclinical and clinical pharmacology findings reported in Diabetes, Obesity and Metabolism [2] demonstrate dose-dependent metabolic and appetite-related responses consistent with GLP-1 receptor activation
US$ 23.46
US$ 24.37
US$ 22.85
US$ 23.97
US$ 20.85
US$ 24.20
